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Introduction
Radical prostatectomy is considered the “gold 
standard” treatment for patients with localised 
prostate cancer and life expectancy greater than 
10 years [1]. Regardless of the technique of the pro-
cedure being performed, its primary goal remains to 
achieve excellent cancer control. However, this has 
to be balanced against the morbidities including uri-
nary incontinence and quality of life [1–5]. With the 
intent of reducing the invasiveness of an open ap-
proach, in 1991 Schuessler et al. performed the first 
laparoscopic prostatectomy [6]. Since then the shift 
from open to endoscopic surgery has begun, as the 
minimally invasive techniques offer magnification 
of the operative field and enable more precise iden-
tification and dissection of the anatomical struc-
tures [7–9]. However, even with the advancement 
of laparoscopic and robotic surgery, the likelihood 
of post-prostatectomy urinary incontinence may be 
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A b s t r a c t
Introduction: Preservation of the bladder neck (BN) has been controversial, as limited excision of the bladder neck 
may result in incomplete resection of the disease. Moreover, the urinary continence rate may not be improved.
Aim: To evaluate the effect of bladder neck sparing on urinary continence, and surgical margins status in prostate 
cancer (PCa) patients treated with laparoscopic radical extraperitoneal prostatectomy.
Material and methods: A retrospective analysis of 295 consecutive patients who had undergone laparoscopic radical 
extraperitoneal prostatectomy for clinically localised prostate cancer in a single institution was performed. Positive 
surgical margin (SM(+)) and urinary continence status at 3, 6, and 12 months were evaluated.
Results: The distribution of SM(+) for pT2, pT3, and pT4a was 15.3% (27/176), 49.1% (58/118), and 100% (1/1), 
respectively. Overall, there were 55.61%, 80.61%, and 84.69% of men continent at 3, 6, and 12 months, respectively. 
However, when limiting the analysis to those who did not receive adjuvant radiotherapy within 12 months following 
surgery, urinary continence rates were 59.23%, 85.86%, and 90.21% at 3, 6, and 12 months, respectively. Preoper-
ative prostate-specific antigen (PSA) and pathological T stage were identified as significant predictors of positive 
surgical margins.
Conclusions: Laparoscopic radical extraperitoneal prostatectomy with bladder neck preservation has been a safe 
procedure which has resulted in good functional outcome. We observed a relatively high incidence of positive surgi-
cal margins which could be attributed to a large number of extracapsular disease cases.
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high and ranges, depending on the definition of uri-
nary control, from 2.5% to 87% [10]. To improve the 
functional outcomes of the surgery, several different 
centres across the world have developed more re-
fined techniques which allow for nerve sparing, api-
cal dissection and bladder neck preservation (BNP) 
[7, 11, 12]. However, BNP remains controversial, as 
it may come at the cost of high risk of positive sur-
gical margins, compromising the disease prognosis, 
and not necessarily being able to guarantee a better 
continence outcome [13, 14].
Aim
Therefore, the aim of this study is to evaluate the 
effect of bladder neck sparing on urinary continence 
and surgical margins status in prostate cancer pa-
tients treated with laparoscopic radical extraperito-
neal prostatectomy.
Material and methods
Clinical and histological data of 295 consecutive 
patients, who had undergone laparoscopic radical 
extraperitoneal prostatectomy (LRP) for clinically 
localised prostate cancer in a single institution, be-
tween January 2007 and December 2012, were re-
viewed from a  prospectively maintained database. 
All of the procedures were performed by two expe-
rienced surgeons. Bladder neck preservation tech-
nique was applied with a bladder neck circumference 
approximating the urethral stump before anasto-
mosis, as previously described [7, 8]. As BN sparing 
was performed consistently, we did not exclude pa-
tients with median lobe hypertrophy or those with 
high-risk features from this bladder neck dissection 
technique. All pathological examinations were per-
formed by a  single pathologist. A  positive surgical 
margin was defined as the presence of cancer cells 
at the inked margin of the resected specimen. 
Perioperative parameters such as operative 
time, transfusion and conversion rates, catheterisa-
tion time, pathological results and positive surgical 
margin rates were reviewed from our prospectively 
maintained database. Urinary continence status was 
assessed with the ICIQ-UI Short Form questionnaire 
at 3, 6 and 12 months after every laparoscopic rad-
ical prostatectomy [15]. Postoperative continence 
was defined as the absence of need for any pads. 
Patients who had less than 12 months of follow-up 
were excluded from the postoperative continence 
status analysis. A  total of 196 men met these in-
clusion criteria and were analysed respectively. Fol-
low-up comprised clinical examination and eval-
uation of the PSA levels at 3, 6, 9 and 12 months 
after laparoscopic radical prostatectomy and every 
6 months thereafter. Biochemical recurrence (BCR) 
was defined as two consecutive PSA levels of > 0.2 ng/ 
ml after LRP.
Statistical analysis
The Shapiro-Wilk test was used to examine 
for normal distribution. Results were presented as 
mean values ± standard deviation (± SD) when data 
were normally distributed, otherwise as median, 
1st and 3rd quartile (Q1, Q3). Parametric t test and 
Mann-Whitney U tests were applied as appropriate. 
The associations between parameters were exam-
ined using Spearman’s rank correlation coefficient. 
Kaplan-Meier method and the log rank test were 
used for biochemical recurrence-free survival anal-
yses. For all statistical tests a  p value < 0.05 was 
considered statistically significant. The Statistical 
Package for the Social Sciences (SPSS), version 19, 
was used for all statistical analyses.
Results
Patient demographic data are presented in Ta-
ble I  and intraoperative data in Table II. The mean 
patient age was 62 years (range: 42–78 years). The 
most common preoperative Gleason score was 6. 
Table I. Patient demographics
Variable Value
Age, mean ± SD [years] 62 ±6.40
PSA, mean ± SD [ng/ml] 10.38 ±12.21
Median Gleason score 6
Preoperative Gleason score [%]:
4 9
5 16
6 47
7 22
8 3
9 3
SD – standard deviation
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Mean operative time (from skin incision to skin clo-
sure) was 156 min (range: 85–370 min). The total 
perioperative transfusion rate was 3.7%, and the 
intraoperative transfusion rate was 1.3% (4 pa-
tients required blood transfusion during surgery). 
Five patients required conversion to an open proce-
dure: one occurred in an obese man due to the lack 
of extra-long instruments and the inability to per-
form anastomotic suturing; two others were due to 
suboptimal vision due to camera malfunction; and 
two cases were converted to open surgery due to 
problems with the gas insufflator and the inability to 
maintain adequate intra-abdominal pressure.
There were no intraoperative complications. The 
mean hospital stay was 8 days (range: 2–14 days) 
and the mean catheter time was 19 days (range: 
9–36 days). The median follow-up was 36 months 
(range: 12–60 months).
Oncologic results are presented in Table III. The 
most common Gleason score determined postop-
eratively was 6. The distribution of pathologic stag-
es was 59.7% pT2, 40.0% pT3 and 0.3% pT4. The 
overall positive surgical margin rate was 29.15% 
(86 cases). Of those, 30.2% (27/86) were observed 
in men with pT2 stage of prostate cancer, 67.4% 
(58/86) were detected in patients with pT3 stage, 
and 1.16% (1/86) of SM(+) was noted in a man with 
pT4a disease. The distribution of SM(+) for pT2, pT3, 
and pT4a was 15.3% (27/176), 49.1% (58/118), and 
100% (1/1), respectively. 
Overall, 59 patients (20.0%) had an isolated 
SM(+) and 27 men (13.7%) had multiple positive 
margins. Of those, 29.0% of patients (25/86) had 
a solitary apical SM(+), whereas an isolated positive 
surgical margin was present in posterolateral, poste-
rior, lateral and anterior location in 16.3% (14/86), 
12.8% (11), 4.7% (4/86), and 3.5% (3/86) of cases, 
respectively. 
The bladder neck was a positive margin in 14 in-
stances (16.3%), and in 12 out of those cases 
(85.7%) it was in combination with an SM(+) at 1 or 
2 other sites (apex in 6 men, anterior in 4 cases, and 
posterolateral in 4 patients).
Postoperative urinary continence status was as-
sessed in 196 patients at 3, 6 and 12 months after 
surgery (Table IV). Overall, there were 55.61%, 80.61%, 
and 84.69% of men continent, respectively. How-
ever, when limiting the analysis to those who did 
not receive adjuvant radiotherapy within 12 months 
following surgery (184 men), urinary continence 
rates were 59.23%, 85.86%, and 90.21% at 3, 6, and 
12 months, respectively.
Table II. Intraoperative data
Variable Value
Operative time, mean ± SD [min] 156 ±47
Transfusion rate (%) 1.3
Conversion rate (%) 1.6
LOS, mean ± SD [days] 8.05 ±2.80
Catheterisation time, mean ± SD [days] 19.23 ±5.68
LOS – length of hospital stay 
Table III. Oncologic results
Variable Value
pT2a, n (%) 40 (13.6)
pT2b, n (%) 15 (5.1)
pT2c, n (%) 121 (41.0)
pT3a, n (%) 96 (32.0)
pT3b, n (%) 22 (7.5)
pT4a, n (%) 1 (0.3)
Median Gleason score 6
Postoperative Gleason score (%):
4 5.1
5 18.9
6 38.3
7 30.2
8 4.1
9 3.4
Overall SM(+), n (%) 86 (29.15)
SM(+) by stage: 
pT2a, n (%) 2 (5.0)
pT2b, n (%) 4 (26.6)
pT2c, n (%) 21 (17.3)
pT3a, n (%) 44 (45.8)
pT3b, n (%) 14 (63.6)
pT4a, n (%) 1 (100)
SM(+) – positive surgical margin
Videosurgery and Other Miniinvasive Techniques 3, September/2014
Laparoscopic radical prostatectomy with bladder neck preservation: positive surgical margin and urinary continence status
365
Overall, detectable prostate-specific antigen lev-
els of > 0.20 ng/ml were found in 14 patients (7.1%). 
Six cases were detected in patients with negative 
surgical margins (SM(–)) (2.8% of the SM(–) group), 
and 8 men had positive SM (9.3% of the SM(+) 
group). The mean time to detectable PSA recurrence 
was 22.05 months in patients with negative surgi-
cal margins and 18.17 months in men with positive 
surgical margins, p = 0.182. The overall biochemical 
recurrence-free survival rate was 74.2% (141/190) at 
3 years. 
Four patients developed bone metastases. Of 
those, 3 had SM(–) and 1 had SM(+). The median 
time to a positive bone scan was 40 months. 
Adjuvant or salvage radiation treatment (RXT) 
was provided to 57 men during 3 years of follow-up. 
Of those, 12 underwent radiotherapy during the first 
12 months of follow-up, 17 men had RXT between 
12 and 24 months following surgery, and 28 patients 
received radiation treatment in the third year of fol-
low-up. For patients with presumed local recurrence 
(2 cases) who refused RXT, expectant management 
was offered. Men with a  systematic relapse were 
managed with androgen deprivation treatment. 
The surgical margin status was significantly cor-
related with the preoperative PSA (p = 0.008), clini-
cal T stage (p = 0.006), and pathological T stage (p < 
0.001). Patients with positive surgical margins more 
commonly had a  lesion staged as cT2b and, less 
frequently, a tumour determined as cT2a on digital 
rectal examination than men with negative surgical 
margins (15.1% and 20.9% vs. 33.0% and 11.0%, re-
spectively). Moreover, a higher pathological T stage 
of prostate cancer (pT3a and pT3b) was observed 
more frequently in men with SM(+) compared to 
those with SM(–) (51.1% and 16.3% vs. 24.9% and 
4.3%, respectively). Preoperative median PSA level in 
patients with negative surgical margins was lower 
than in cases with SM(+) (7.70 ng/ml (5.55; 10.80) 
vs. 8.38 ng/ml (6.87; 11.81), respectively). 
There was no statistical difference in the age of 
patients when analysed by the status of surgical 
margins (61.85 ±6.08 years in men with negative 
SM, and 62.79 ±7.07 years in men with SM(+), p = 
0.249). Similarly, there was no statistical difference 
observed in the median biopsy and postoperative 
Gleason score when analysed by the SM status (the 
median biopsy and postoperative Gleason score 
in both groups of men was 6, p = 0.639, and p = 
0.071, respectively). To further evaluate a  possible 
association of Gleason score with surgical margin 
status, we also analysed outcomes by Gleason score 
into low, intermediate or high grades based on the 
Gleason score of 4–6, 7, and 8–10, respectively. This 
analysis identified no statistical difference in the 
frequency of those three biopsy and postoperative 
grades in men with SM(+) and SM(–) (p = 0.450, and 
p = 0.162, respectively).
The logistic regression analysis indicated that 
preoperative PSA, and pathological T stage cor-
related with positive surgical margin (p = 0.008, r = 
0.154, and p < 0.001, r = 0.371, respectively). There 
was no correlation between surgical margin status 
and the biopsy and postoperative Gleason score, or 
clinical T stage.
Surgical margin status had a significant effect on 
the 3-year biochemical recurrence-free survival, with 
a higher percentage of men without PSA recurrence 
in those with negative surgical margins (89.9% vs. 
55.8%, respectively, p < 0.001) (Figure 1). 
To evaluate the prognostic value of preoperative 
PSA, we divided the patients with and without pos-
itive surgical margins into those with PSA ≤ 10 ng/
ml, and > 10 ng/ml. Men with PSA > 10 ng/ml had 
significantly shorter time to biochemical recurrence 
(83.3% vs. 92.3% in cases with SM(–), respectively, 
p = 0.047, and 39.2% versus 65.4% in patients with 
SM(+), respectively, p = 0.027) (Figures 2 and 3).
Discussion
Urinary continence in men depends on the co-
ordinated function of two independent sphincter 
mechanisms, which are the proximal urethral sphinc-
ter, located within the bladder neck, and the distal 
urethral sphincter, anchored below the verumonta-
num [16, 17]. Injury to either one can result in the 
loss of urinary control [18, 19]. 
Table IV. Postoperative continence rates with 
(RXT+) and without adjuvant radiotherapy (RXT–)
Postoperative 
time [months]
Continence rate 
(RXT+) (%)
Continence rate 
(RXT–) (%)
3 55.61 59.23
6 80.61 85.86
12 84.69 90.21
Continence rate (RXT+) – continence rates of all patients including those 
who underwent adjuvant radiotherapy, continence rate (RXT–) – continence 
rates of patients who did not receive adjuvant radiotherapy
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Figure 1. Kaplan-Meier curve showing the bio-
chemical recurrence-free survival rates (progres-
sion PSA greater than 0.2  ng/ml) according to 
surgical margin status
BCR-free survival – biochemical recurrence-free survival; SM(+) 
– positive surgical margin, SM(–) – negative surgical margin,  
PSA – prostate-specific antigen
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Figure 2. Kaplan-Meier curve showing biochem-
ical recurrence-free survival rates (progression 
PSA greater than 0.2 ng/ml) according to preop-
erative PSA strata in men with negative surgical 
margin
BCR-free survival – biochemical recurrence-free survival, PSA – pro-
state-specific antigen
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Figure 3. Kaplan-Meier curve showing biochem-
ical recurrence-free survival rates (progression 
PSA greater than 0.2 ng/ml) according to preop-
erative PSA strata in men with positive surgical 
margin
BCR-free survival – biochemical recurrence-free survival, PSA – pro-
state-specific antigen
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Radical prostatectomy, which most commonly 
leads to bladder neck dysfunction, may also cause 
intraoperative damage of the neuronal innervation, 
which itself can adversely affect the continence 
mechanisms [18, 20]. In order to preserve these crit-
ical structures, and consequently improve function-
al outcome, various technical modifications have 
been introduced, including neurovascular bundle 
and bladder neck preservation [7, 11, 12]. However, 
despite BNP during radical prostatectomy being per-
formed for more than 20 years, it still remains un-
clear how this technical refinement affects urinary 
continence, particularly in the long term, but more 
importantly whether or not it carries a  risk for the 
positive surgical margins [10, 11, 21]. 
In our study, overall urinary continence rates 
at 3, 6, and 12 months were 55.61%, 80.61%, and 
84.69%, respectively. However, this analysis included 
data from incontinent men who had adjuvant radio-
therapy within 12 months of surgery. To eliminate 
a potential bias, associated with an adverse radio-
therapeutic effect on the continence mechanisms, 
we excluded those patients from the analysis. The 
resultant data showed greater continence rates at 
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all 3 points of assessment (59.23%, 85.86%, and 
90.21% at 3, 6, and 12 months, respectively). These 
results are comparable with current literature [4, 7, 
22, 23].
Bladder neck preservation carries a potential risk 
for positive surgical margins as limited excision of 
the bladder neck may result in the incomplete resec-
tion of the disease. In our study, the overall SM(+) 
rate was 29.15%. The distribution of SM(+) for pT2, 
pT3, and pT4a was 15.3% (27/176), 49.1% (58/118), 
and 100% (1/1), respectively. 
Several previous studies have addressed the risk 
of SM(+) after LRP. A positive surgical margin rate of 
16.6% to 39.4% has been reported [24, 25]. In stud-
ies evaluating the effect of bladder neck preserva-
tion on tumour resection, the overall SM(+) rate was 
up to 32% [25]. A review of 555 radical prostatecto-
mies found the presence of positive surgical margins 
in 32% of patients [26]. In that study 54% of men 
with extracapsular extension of the disease had 
SM(+). Deliveliotis et al. reported a  21% incidence 
of SM(+) in patients who underwent radical prosta-
tectomy with a BNP procedure, whereas Poon et al. 
described a 27.4% positive surgical margin rate with 
bladder neck preservation [27, 28]. Similarly, a recent 
report from the U.K., which evaluated the oncological 
results in 575 patients who underwent endoscopic 
extraperitoneal radical prostatectomy, identified 
135 men (23.5%) with positive surgical margins [29]. 
The SM(+) rate for pT2 disease was 66/406 patients 
(16.3%) and for pT3 disease it was 68/168 patients 
(40.5%). Terakawa et al. reported an overall positive 
surgical margin rate of 39.4%, with a rate of 30.2% 
found in patients with pT2 disease and 71.0% in pa-
tients with pT3 disease [25].
However, several studies evaluating the onco-
logical outcome of laparoscopic and robotic radical 
prostatectomies found lower rates of SM(+) [5, 7, 22, 
30, 31]. The review of 1,564 cases from the Memori-
al Sloan-Kettering Cancer Center in the U.S.A. report-
ed that only 13% of patients who underwent laparo-
scopic prostatectomy had positive surgical margins 
[30]. Similar results were observed in research from 
Harvard [31]. In a recent study of 95 men who un-
derwent robot-assisted laparoscopic radical prosta-
tectomy with BNP, the overall SM(+) rate was 14.7% 
[22]. Generally, in more recent reports, the observed 
better oncological outcome can likely be attributed 
to the better surgical technique, and the earlier tu-
mour detection, but also to the low rate of extracap-
sular disease [7]. In our study, the overall positive 
surgical margin rate was relatively high. This is most 
likely associated with at least twice greater frequen-
cy of extracapsular disease present in our patients 
(40.33%) than reported in other series with lower 
SM(+) rates (4.5–27%) [5, 7, 30–32]. It should be 
emphasized that the use of radical prostatectomy 
for high-risk PCa and the use of minimally invasive 
treatment alternatives for low-risk disease have be-
come more popular in many countries in Europe and 
the U.S.A. over the last decade [33, 34]. It is likely 
that this trend will continue, and the patients with 
very low-risk disease or men older than 70 years 
who are candidates for active surveillance will select 
minimally invasive surgery, whereas in the high-risk 
group, indications for radical prostatectomy may 
expand, because this surgery with extended pelvic 
lymph node dissection might improve the oncologi-
cal outcome [35]. Further polarization of radical pros-
tatectomy into a minimally invasive procedure with 
the goal of preserving function or extensively radical 
prostatectomy aiming to achieve extensive resection 
will possibly become more distinct in future.
In our study, we demonstrated that the anatomic 
dissection with preservation of the bladder neck is 
an oncologically safe procedure. Although there were 
14 patients with a positive bladder neck margin, the 
great majority (12/14) had SM(+) at multiple sites, 
indicating that a positive surgical margin would have 
occurred regardless of bladder neck preservation.
In the present study, factors correlating with can-
cer aggressiveness (i.e. preoperative PSA and patho-
logical T stage) were independently associated with 
an increased risk of SM(+). Whereas some previous 
groups have also identified those two factors as pre-
dictors of positive margins, others did not confirm 
any correlation with SM(+) and indicated the biopsy 
Gleason score, clinical T stage, prostate volume, in-
terfascial neurovascular bundle dissection and body 
mass index to be independent predictors of SM(+) 
[22, 25, 36, 37].
In this study the presence of positive surgical 
margins significantly affected the 3-year biochemi-
cal recurrence-free survival rate (55.8% vs. 89.9% in 
SM(+) and SM(–), respectively, p < 0.001). The effect 
of positive surgical margins status on 3-year bio-
chemical recurrence-free survival rates was partic-
ularly pronounced in those with preoperative PSA > 
10 ng/ml (39.2% vs. 65.4% in men with PSA ≤ 10 ng/
ml, p = 0.027). Although there were no such analyses 
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performed in previously reported studies describing 
results of laparoscopic radical prostatectomy with 
bladder neck preservation, the importance of the 
positive surgical margins and preoperative PSA level 
on the risk of biochemical recurrence has been well 
recognised [38–40].
It is well known that SM(+)s significantly increase 
the risk of BCR. However, there is a  lack of associ-
ation between positive margins and cancer-specific 
mortality (CSM), which is likely due to the highly var-
iable natural history of biochemical recurrence. The 
data evaluating the risk of metastatic progression 
and death in men with SM(+) and BCR have stressed 
the importance of other adverse clinical and patho-
logical parameters than just the presence of positive 
margins alone, as absence of those features in men 
with SM(+)s may be associated with an indolent 
form of BCR [41]. In a recent, large population-based 
study using the Surveillance Epidemiology and End 
Results (SEER) cancer registry, in which patients were 
followed for a  median of 4.2 years, a  1.7-fold in-
creased risk of death from PCa was observed among 
men with positive compared with negative surgical 
margins [42]. However, after adjustments for adverse 
pathological features, these findings held true for 
only high-grade tumours or extraprostatic disease 
(pT3). Another study by Chalfin et al. showed that an 
SM(+) was an independent predictor of prostate-can-
cer-specific mortality (hazard ratio (HR) was 1.4), but 
the impact was of a modest effect compared to the 
Gleason score (HR = 5.7–12.6) and pathological stage 
(HR = 2.2–11.0) [43]. Several other studies have failed 
to identify SM(+)s to be associated with an increased 
risk of systemic progression and cancer-specific mor-
tality [44–46]. Similarly, the most recent report with 
the longest follow-up indicated that SM(+)s alone 
were not associated with a  significantly increased 
risk of CSM within 15 years [47]. In this study men 
with SM(+) had 1.04-fold risk of death from PCa com-
pared to those with negative surgical margins. 
For the time being, it remains unclear why pos-
itive surgical margins may affect probability of BCR 
but not distant metastasis or cancer-specific mor-
tality, particularly as SM(+)s increase the risk of 
disease recurrence [48]. It is likely that competing 
causes of mortality may obscure the detrimental 
impact of SM(+)s on death due to PCa [46, 49]. 
However, urologists should strive to avoid positive 
surgical margins, as they increase the risk of BCR 
and consequently the need for secondary treatment 
and may be a source of anxiety among affected pa-
tients [50, 51].
The present study has some limitations. Our re-
search is retrospective and it is, therefore, subject to 
bias and limitations frequently associated with this 
type of study. Moreover, we have not analysed the ef-
fect of size of the prostate, and the presence of a large 
middle lobe on the functional outcomes. In addition, 
median follow-up was relatively short (3 years), and 
consequently the sample size analysed at 12, 24 and 
36 months of follow-up was relatively small. Addition-
ally, data regarding postoperative urinary continence 
at 12 months of follow-up were available in 196 out of 
295 patients who underwent the surgery.
Conclusions
Laparoscopic radical extraperitoneal prostatec-
tomy with bladder neck preservation proved to be 
a safe procedure resulting in a good functional out-
come. We observed a  relatively high incidence of 
positive surgical margins. This could be attributed to 
a large number of extracapsular disease cases. The 
data regarding the prognostic factors for positive 
surgical margins identified in our study are the same 
as noted previously in the series describing LRP with 
BNP. Further prospective research is warranted to 
further investigate the effect of the size of the pros-
tate, and the presence of a large middle lobe on the 
functional outcomes following laparoscopic radical 
prostatectomy with bladder neck sparing.
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